KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia
Clinical trial NCT05421429 · COMPLETED
Trial details
- NCT number
- NCT05421429
- Sponsor
- Suzhou Alphamab Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2024-01-17
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.